7*24 快讯

纳斯达克生物科技指数收涨超1.2%

成分股ARS Pharmaceuticals收涨20.37%,美国食品药品管理局(FDA)批准其Anaphylaxis Nasal Spray疗法之后,券商Raymond James上调评级;

Xeris Pharmaceuticals、Taysha Gene、Fortrea Holdings、Atea涨12.89%-9.25%,23Andme Holding Co.则收跌5.10%,EyePoint Pharmaceuticals跌6.10%,Mirum Pharmaceuticals跌8.16%,Immunitybio Inc.跌14.93%。